168 related articles for article (PubMed ID: 22413755)
1. Atypical subacute cutaneous lupus erythematosus presenting as lichen planus pemphigoides with autoantibodies to C-terminus of BP180, desmoglein 1 and SS-A/Ro antigen.
Inoue Y; Adachi A; Ueno M; Fukumoto T; Nishitani N; Fujiwara N; Yamada Y; Ohyama B; Tsuruta D; Hashimoto T
J Dermatol; 2012 Nov; 39(11):960-2. PubMed ID: 22413755
[No Abstract] [Full Text] [Related]
2. A case of lichen planus pemphigoides with autoantibodies to the NC16a and C-terminal domains of BP180 and to desmoglein-1.
Sekiya A; Kodera M; Yamaoka T; Iwata Y; Usuda T; Ohzono A; Yasukochi A; Koga H; Ishii N; Hashimoto T
Br J Dermatol; 2014 Nov; 171(5):1230-5. PubMed ID: 24813536
[TBL] [Abstract][Full Text] [Related]
3. Lichen planus pemphigoides: detection of anti-BP 180 antibodies by ELISA and immunoblotting tests.
Barnadas MA; Roé E; Dalmau J; Alomar A; Martínez L; Gelpí C
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1360-1. PubMed ID: 20337815
[No Abstract] [Full Text] [Related]
4. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
[TBL] [Abstract][Full Text] [Related]
5. [Anti-desmoglein 1 and 3 antibody, anti-BP180(NC16a) antibody, anti-BP230 antibody].
Amagai M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():614-7. PubMed ID: 20942145
[No Abstract] [Full Text] [Related]
6. IgG autoantibodies from a lichen planus pemphigoides patient recognize the NC16A domain of the bullous pemphigoid antigen 180.
Skaria M; Salomon D; Jaunin F; Friedli A; Saurat JH; Borradori L
Dermatology; 1999; 199(3):253-5. PubMed ID: 10592407
[TBL] [Abstract][Full Text] [Related]
7. Lichen Planus Pemphigoides Mimicking Toxic Epidermal Necrolysis.
Ondhia C; Kaur C; Mee J; Natkunarajah J; Singh M
Am J Dermatopathol; 2019 Nov; 41(11):e144-e147. PubMed ID: 31145106
[TBL] [Abstract][Full Text] [Related]
8. Atezolizumab-induced lichen planus pemphigoides in a patient with metastatic non-small-cell lung cancer.
Senoo H; Kawakami Y; Yokoyama E; Yamasaki O; Morizane S
J Dermatol; 2020 Apr; 47(4):e121-e122. PubMed ID: 31984550
[No Abstract] [Full Text] [Related]
9. Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering.
Hübner F; Langan EA; Recke A
Front Immunol; 2019; 10():1389. PubMed ID: 31312198
[TBL] [Abstract][Full Text] [Related]
10. Bullous lichen planus accompanied by elevation of serum anti-BP180 autoantibody: A possible transitional mechanism to lichen planus pemphigoides.
Fujii M; Takahashi I; Honma M; Ishida-Yamamoto A
J Dermatol; 2017 Jun; 44(6):e124-e125. PubMed ID: 28105695
[No Abstract] [Full Text] [Related]
11. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
[TBL] [Abstract][Full Text] [Related]
12. Desmoglein1 and BP 180 ELISA indexes correlating with disease activity in a patient with coexisting pemphigus foliaceus and bullous pemphigoid.
Ando S; Sato-Matsumura KC; Kasai M; Nemoto-Hasebe I; Hoshina D; Ohyama B; Hashimoto T; Shimuzu H
Clin Exp Dermatol; 2009 Dec; 34(8):e995-6. PubMed ID: 20055881
[No Abstract] [Full Text] [Related]
13. Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens.
Yoon KH; Kim SC; Kang DS; Lee IJ
Eur J Dermatol; 2000; 10(3):212-4. PubMed ID: 10725820
[TBL] [Abstract][Full Text] [Related]
14. [Case no. 1. Bullous dermatosis].
Ortonne N
Ann Pathol; 2013 Jun; 33(3):178-83. PubMed ID: 23790657
[No Abstract] [Full Text] [Related]
15. Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.
Andreadis D; Lorenzini G; Drakoulakos D; Belazi M; Mihailidou E; Velkos G; Mourellou-Tsatsou O; Antoniades D
Eur J Oral Sci; 2006 Oct; 114(5):374-80. PubMed ID: 17026501
[TBL] [Abstract][Full Text] [Related]
16. Circulating IgE anti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients.
Ma L; Wang M; Wang X; Chen X; Zhu X
J Dermatol Sci; 2015 Apr; 78(1):76-7. PubMed ID: 25797173
[No Abstract] [Full Text] [Related]
17. Lichen planus pemphigoides developing from patient with non-small-cell lung cancer treated with nivolumab.
Sato Y; Fujimura T; Mizuashi M; Aiba S
J Dermatol; 2019 Oct; 46(10):e374-e375. PubMed ID: 31062404
[No Abstract] [Full Text] [Related]
18. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
[No Abstract] [Full Text] [Related]
19. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
20. Parallel fluctuation of anti-desmoglein 3 and anti-BP180 autoantibody titres in a patient with bullous pemphigoid.
Takahashi H; Anzai H; Suzuki Y; Tanikawa A; Amagai M; Nishikawa T
Clin Exp Dermatol; 2004 Nov; 29(6):608-11. PubMed ID: 15550133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
